Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)
NCT02298647
·
clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Transition to BioMetabol
Conditions
Hepato-splenomegaly
Dysostosis Multiplex
Seizures
Mental Retardation
Sponsor
CENTOGENE GmbH Rostock